inme olgularında protrombin gen mutasyonlarının rolü - Süleyman ...

658. KAYNAKLAR1. Goldstein LB, Adams R, Alberts MJ, Appel LJ, Brass LM, Bushnell CD, et al. Primary prevention ofischemic stroke: a guideline from the American Heart Association/American Stroke AssociationStroke Council. Stroke 2006; 37: 1583-6332. Goldstein LB, Amarenco P. Prevention and health services delivery. Stroke 2004; 35:401-33. Dickerson LM, Carek PJ, Quattlebaum RG. Prevention of recurrent ischemic stroke. Am FamPhysician 2007;76(3):382-84. Kumral E. Serebrovasküler hastalıkların epidemiyolojisi. Türkiye Klinikleri Nöroloji 2004; 2(1):15-215. Gedikli Ö, Baykan M. İnmenin önlenmesinde statinler. Anadolu Kardiyoloji Dergisi 2008;8:217-226. Juo SHH, Sacco RL. Genetics of stroke. In: Rowland LP (Ed.). Merritt’s Neurology. 11 th ed.Philadelphia: Lippincott Williams & Wilkins; 2005: p.305-87. Fields MC, Levine SR. Thrombophilias and stroke: diagnosis, treatment, and prognosis. J ThrombThrombolysis 2005; 20: 113-268. Pezzini A, Grassi M , Del Dotto E, Archetti S, Spezi R, Vergani V, et al. Cumulative effect ofpredisposing genotypes and their interaction with modifiable factors on the risk of ischemic stroke inyoung adults. Stroke 2005;36:533-99. World Health Organization. Recommendations on stroke prevention, diagnosis and therapy. Stroke1989; 20:1407-3110. Kidwell CS, Alger JR, Di Salle F, Starkman S, Villablanca P, Bentson J, et al. Diffusion MRI inpatients with transient ischemic attacks. Stroke 1999;30:1174-8011. Özdemir G. Serebrovasküler hastalıklardan stroğa yaklaşım. Türkiye Klinikleri Nöroloji 2004; 2: 1-1412. Sacco RL. Pathogenesis, classification, epidemiology of cerebrovascular disease. In: Rowland LP(Ed.). Merritt’s Neurology. 11 th ed. Philadelphia: Lippincott Williams & Wilkins; 2005:275-9013. Biler J, Love BB. Ischemic cerebrovascular disease. In: Bradley WG (Ed.). Neurology in ClinicalPractice. 14 th ed. Philadelphia: Butterworth Heinemann; 2004:1197-25114. Berger C, Fiorelli M, Steiner T, Schäbitz WR, Bozzao L, Bluhmki E, et al. Hemorrhagictransformation of ischemic brain tissue: Asymptomatic or symptomatic? Stroke 2001;32:1330-3515. Yemişçi M, Gürer G, Dalkara T. İskemik inmede gelişen fizyopatolojik olaylar. Türkiye KlinikleriNöroloji 2004; 2: 22-3016. Astrup J, Siesjö BK, Symon L. Thresholds in cerebral ischemia-the ischemic penumbra. Stroke 1981;12:723-2517. Fisher M, Ratan R. New perspectives on developing acute stroke theraphy. Ann Neurol 2003;53:10–2018. Ay H, Dalkara T. İskemik penumra ve terapötik zaman aralığını etkileyen faktörler. SerebrovaskülerHastalıklar. Editör: Balkan S. Ankara: Güneş Tıp Kitabevi Yayınları, 2009: 29-36